Alessandro Grattoni
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Electrospun Nanofibers in Biomedical Applications
Papers in
-
- Microfluidic and Capillary Electrophoresis Applications 37
- Nanopore and Nanochannel Transport Studies 31
- 3D Printing in Biomedical Research 15
- Microfluidic and Bio-sensing Technologies 11
- Nanoplatforms for cancer theranostics 9
- Co-authors
- Mauro Ferrari (23 shared papers)Corrine Ying Xuan Chua (48 shared papers)Jason Sakamoto (3 shared papers)Nicola Di Trani (36 shared papers)Andrea Ballerini (15 shared papers)Daniel H. Fine (16 shared papers)Fernanda P. Pons‐Faudoa (10 shared papers)Marco Farina (12 shared papers)
- Journals
- Advanced Healthcare Materials (7 papers)Journal of Controlled Release (7 papers)Lab on a Chip (6 papers)Biomaterials (6 papers)Advanced Therapeutics (5 papers)
- Partner nations
- United StatesItalyChina
In The Last Decade
Alessandro Grattoni
124 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 147
- Pharmaceutical Science 272
- Biomaterials 539
- Virology 159
- Biomedical Engineering 1.5k
- Surgery 547
Countries citing papers authored by Alessandro Grattoni
This map shows the geographic impact of Alessandro Grattoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Grattoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Grattoni more than expected).
Fields of papers citing papers by Alessandro Grattoni
This network shows the impact of papers produced by Alessandro Grattoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Grattoni. The network helps show where Alessandro Grattoni may publish in the future.
Co-authors
The 25 scholars most cited alongside Alessandro Grattoni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 200 | |
| 2 | 2019 | 160 | |
| 3 | 2018 | 154 | |
| 4 | 2022 | 110 | |
| 5 | 2020 | 101 | |
| 6 | 2021 | 81 | |
| 7 | 2017 | 77 | |
| 8 | 2010 | 74 | |
| 9 | 2013 | 72 | |
| 10 | 2013 | 69 | |
| 11 | 2018 | 67 | |
| 12 | 2018 | 67 | |
| 13 | 2020 | 61 | |
| 14 | 2011 | 54 | |
| 15 | 2018 | 52 | |
| 16 | 2021 | 51 | |
| 17 | 2020 | 50 | |
| 18 | 2019 | 50 | |
| 19 | 2018 | 49 | |
| 20 | 2020 | 48 |
About Alessandro Grattoni
Alessandro Grattoni is a scholar working on Biomedical Engineering, Molecular Biology, Biomaterials, Surgery and Oncology, having authored 128 papers that have together received 3.3k indexed citations. Recurring topics across this work include Microfluidic and Capillary Electrophoresis Applications (37 papers), Nanopore and Nanochannel Transport Studies (31 papers), Nanoparticle-Based Drug Delivery (15 papers), 3D Printing in Biomedical Research (15 papers), Pancreatic function and diabetes (13 papers), Microfluidic and Bio-sensing Technologies (11 papers), HIV Research and Treatment (9 papers) and Nanoplatforms for cancer theranostics (9 papers). The work is most often cited by research in Pharmaceutical Science (272 citations), Biomaterials (539 citations), Virology (159 citations), Biomedical Engineering (1.5k citations) and Surgery (547 citations). Alessandro Grattoni has collaborated with scholars based in United States, Italy and China. Frequent co-authors include Mauro Ferrari, Corrine Ying Xuan Chua, Jason Sakamoto, Nicola Di Trani, Andrea Ballerini, Daniel H. Fine, Fernanda P. Pons‐Faudoa, Marco Farina, Mauro Ferrari and Usha Thekkedath. Their work appears in journals such as Advanced Healthcare Materials, Journal of Controlled Release, Lab on a Chip, Biomaterials and Advanced Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.